Cargando…

Lithium’s effects on therapeutic targets and MRI biomarkers in Parkinson’s disease: A pilot clinical trial()

BACKGROUND: Lithium has a wide range of neuroprotective actions, has been effective in Parkinson’s disease (PD) animal models and may account for the decreased risk of PD in smokers. METHODS: This open-label pilot clinical trial randomized 16 PD patients to “high-dose” (n = 5, lithium carbonate titr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guttuso, Thomas, Shepherd, Rachel, Frick, Luciana, Feltri, M. Laura, Frerichs, Valerie, Ramanathan, Murali, Zivadinov, Robert, Bergsland, Niels
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196787/ https://www.ncbi.nlm.nih.gov/pubmed/37215748 http://dx.doi.org/10.1016/j.ibneur.2023.05.001

Ejemplares similares

Reserve-related activities and MRI metrics in multiple sclerosis patients and healthy controls: an observational study
por: Schwartz, Carolyn E., et al.
Publicado: (2016)

MRI segmentation analysis in temporal lobe and idiopathic generalized epilepsy
por: Goldberg, Hila, et al.
Publicado: (2014)

Relationships Among Circulating Levels of Hemostasis Inhibitors, Chemokines, Adhesion Molecules, and MRI Characteristics in Multiple Sclerosis
por: Ziliotto, Nicole, et al.
Publicado: (2020)

Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis
por: Weinstock-Guttman, Bianca, et al.
Publicado: (2011)

Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals
por: Hagemeier, Jesper, et al.
Publicado: (2017)

Comparison of Standard 1.5 T vs. 3 T Optimized Protocols in Patients Treated with Glatiramer Acetate. A Serial MRI Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2012)

Proteomics and relationship with axonal pathology in multiple sclerosis: 5-year diffusion tensor imaging study
por: Jakimovski, Dejan, et al.
Publicado: (2023)

Decreasing brain iron in multiple sclerosis: The difference between concentration and content in iron MRI
por: Schweser, Ferdinand, et al.
Publicado: (2020)

Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS
por: Tao, Yazhong, et al.
Publicado: (2015)

MRI correlates of disability progression in patients with CIS over 48 months
por: Uher, Tomas, et al.
Publicado: (2014)

Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis
por: Dwyer, Michael G., et al.
Publicado: (2017)

Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study
por: Chitnis, Tanuja, et al.
Publicado: (2013)

Quantifying disease pathology and predicting disease progression in multiple sclerosis with only clinical routine T2-FLAIR MRI
por: Fuchs, Tom A., et al.
Publicado: (2021)

Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changes
por: Jakimovski, Dejan, et al.
Publicado: (2021)

Improved operator agreement and efficiency using the minimum area contour change method for delineation of hyperintense multiple sclerosis lesions on FLAIR MRI
por: Wack, David S, et al.
Publicado: (2013)

Serum neurofilament light chain levels associations with gray matter pathology: a 5‐year longitudinal study
por: Jakimovski, Dejan, et al.
Publicado: (2019)

Measuring Aqueduct of Sylvius Cerebrospinal Fluid Flow in Multiple Sclerosis Using Different Software
por: Laganà, Maria Marcella, et al.
Publicado: (2021)

Retinal Blood Vessel Analysis Using Optical Coherence Tomography (OCT) in Multiple Sclerosis
por: Young, Nicholas, et al.
Publicado: (2023)

The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging
por: Guan, Yi, et al.
Publicado: (2019)

Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2019)

An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice—The MS‐MRIUS Study
por: Zivadinov, Robert, et al.
Publicado: (2016)

Longitudinal analysis of cerebral aqueduct flow measures: multiple sclerosis flow changes driven by brain atrophy
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Neuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2023)

Jugular venous reflux and brain parenchyma volumes in elderly patients with mild cognitive impairment and Alzheimer’s disease
por: Beggs, Clive, et al.
Publicado: (2013)

Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Pilot Study on Quantitative Cervical Cord and Muscular MRI in Spinal Muscular Atrophy: Promising Biomarkers of Disease Evolution and Treatment?
por: Savini, Giovanni, et al.
Publicado: (2021)

Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study
por: Jacobsen, Cecilie, et al.
Publicado: (2020)

Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite MS
por: Zivadinov, Robert, et al.
Publicado: (2020)

CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis
por: Bhan, Alok, et al.
Publicado: (2021)

DeepGRAI (Deep Gray Rating via Artificial Intelligence): Fast, feasible, and clinically relevant thalamic atrophy measurement on clinical quality T2-FLAIR MRI in multiple sclerosis
por: Dwyer, Michael, et al.
Publicado: (2021)

Serum neurofilament light chain and optical coherence tomography measures in MS: A longitudinal study
por: Tavazzi, Eleonora, et al.
Publicado: (2020)

Effect of Treatment with Interferon Beta-1a on Changes in Voxel-Wise Magnetization Transfer Ratio in Normal Appearing Brain Tissue and Lesions of Patients with Relapsing–Remitting Multiple Sclerosis: A 24-Week, Controlled Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2014)

Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis
por: Malyavantham, Kishore, et al.
Publicado: (2015)

MRI biomarkers of freezing of gait development in Parkinson’s disease
por: Sarasso, Elisabetta, et al.
Publicado: (2022)

Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up study
por: Jacobsen, Cecilie, et al.
Publicado: (2021)

Cholinergic neurons in the basal forebrain are involved in behavioral abnormalities associated with Cul3 deficiency: Role of prefrontal cortex projections in cognitive deficits
por: Rapanelli, Maximiliano, et al.
Publicado: (2023)

Improved assessment of multiple sclerosis lesion segmentation agreement via detection and outline error estimates
por: Wack, David S, et al.
Publicado: (2012)

Reserve-building activities in multiple sclerosis patients and healthy controls: a descriptive study
por: Schwartz, Carolyn E., et al.
Publicado: (2015)

The history of lithium therapy
por: Shepherd, Michael
Publicado: (1985)

Cannot write session to /tmp/vufind_sessions/sess_fi4suojgvt0c9piej71dacofc9